<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <?epub June-12-2013?>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">3692046</article-id>
    <article-id pub-id-type="pmid">23761446</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkt529</article-id>
    <article-id pub-id-type="publisher-id">gkt529</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>TMA Navigator: network inference, patient stratification and survival analysis with tissue microarray data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Lubbock</surname>
          <given-names>Alexander L. R.</given-names>
        </name>
        <xref ref-type="aff" rid="gkt529-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Katz</surname>
          <given-names>Elad</given-names>
        </name>
        <xref ref-type="aff" rid="gkt529-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Harrison</surname>
          <given-names>David J.</given-names>
        </name>
        <xref ref-type="aff" rid="gkt529-AFF1">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Overton</surname>
          <given-names>Ian M.</given-names>
        </name>
        <xref ref-type="aff" rid="gkt529-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="corresp" rid="gkt529-COR1">*</xref>
      </contrib>
    </contrib-group>
    <aff id="gkt529-AFF1"><sup>1</sup>MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK, <sup>2</sup>Division of Pathology, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK and <sup>3</sup>School of Medicine, University of St Andrews, North Haugh, St Andrews KY16 9TF, UK</aff>
    <author-notes>
      <corresp id="gkt529-COR1">*To whom correspondence should be addressed. Tel: <phone>+44 131 332 2471</phone>; Fax: <fax>+44 131 467 8456</fax>; Email: <email>ian.overton@igmm.ed.ac.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <month>7</month>
      <year>2013</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>11</day>
      <month>6</month>
      <year>2013</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>11</day>
      <month>6</month>
      <year>2013</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>41</volume>
    <issue>Web Server issue</issue>
    <fpage>W562</fpage>
    <lpage>W568</lpage>
    <history>
      <date date-type="received">
        <day>31</day>
        <month>1</month>
        <year>2013</year>
      </date>
      <date date-type="rev-recd">
        <day>13</day>
        <month>5</month>
        <year>2013</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>5</month>
        <year>2013</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2013. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2013</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/3.0/">
        <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Tissue microarrays (TMAs) allow multiplexed analysis of tissue samples and are frequently used to estimate biomarker protein expression in tumour biopsies. TMA Navigator (<ext-link ext-link-type="uri" xlink:href="www.tmanavigator.org">www.tmanavigator.org</ext-link>) is an open access web application for analysis of TMA data and related information, accommodating categorical, semi-continuous and continuous expression scores. Non-biological variation, or batch effects, can hinder data analysis and may be mitigated using the ComBat algorithm, which is incorporated with enhancements for automated application to TMA data. Unsupervised grouping of samples (patients) is provided according to Gaussian mixture modelling of marker scores, with cardinality selected by Bayesian information criterion regularization. Kaplan–Meier survival analysis is available, including comparison of groups identified by mixture modelling using the Mantel-Cox log-rank test. TMA Navigator also supports network inference approaches useful for TMA datasets, which often constitute comparatively few markers. Tissue and cell-type specific networks derived from TMA expression data offer insights into the molecular logic underlying pathophenotypes, towards more effective and personalized medicine. Output is interactive, and results may be exported for use with external programs. Private anonymous access is available, and user accounts may be generated for easier data management.</p>
    </abstract>
    <counts>
      <page-count count="7"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>1 July 2013</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec>
    <title>INTRODUCTION</title>
    <p>Oncogenic selection manifests through dysregulated pathways (<xref ref-type="bibr" rid="gkt529-B1">1</xref>). Protein abundance and post-translational modifications (PTMs) are key determinants of network/pathway activity; therefore, functional proteomics is particularly important for understanding signalling networks underlying cancer progression, including evolution of drug resistance and metastasis (<xref ref-type="bibr" rid="gkt529-B2">2</xref>). Tissue microarrays (TMAs) enable study of protein (and RNA) expression in <italic>ex vivo</italic> material, typically formalin-fixed paraffin-embedded tissue obtained at operation (<xref ref-type="bibr" rid="gkt529-B3">3</xref>). Multiplexed immunohistochemical analysis across arrays of tissue cores efficiently derives protein expression measurements for many specimens (<xref ref-type="bibr" rid="gkt529-B4">4</xref>). TMAs also provide greater consistency than whole section approaches due to simultaneous processing of multiple samples in identical conditions, among other features (<xref ref-type="bibr" rid="gkt529-B5">5</xref>). Clinical subtyping frequently uses TMAs, for example to determine estrogen receptor-α (ER-α) and HER2/neu status in breast cancer (<xref ref-type="bibr" rid="gkt529-B5 gkt529-B6 gkt529-B7">5–7</xref>). Although alternative techniques afford greater throughput for estimating protein expression, notably reverse phase protein arrays (<xref ref-type="bibr" rid="gkt529-B8">8</xref>) and mass spectrometry (<xref ref-type="bibr" rid="gkt529-B9">9</xref>), TMAs have particular advantages. These include identification of marker subcellular localization and discrimination of tumour compartments (e.g. stroma) using little material and without requirement for laser capture microdissection or cell fractionation (<xref ref-type="bibr" rid="gkt529-B10">10</xref>,<xref ref-type="bibr" rid="gkt529-B11">11</xref>). Furthermore, TMAs provide potential to identify single cell expression distributions (<xref ref-type="bibr" rid="gkt529-B12">12</xref>). TMA Navigator provides an integrated platform for TMA data, designed to handle both categorical, semi-continuous and continuous scoring, e.g. (<xref ref-type="bibr" rid="gkt529-B13 gkt529-B14 gkt529-B15 gkt529-B16">13–16</xref>). User-friendly interactive access is provided for data processing, investigation of marker networks and risk stratification. An option is available for reduction of batch effects, which are common, for example where data are split across multiple TMA blocks (<xref ref-type="bibr" rid="gkt529-B17">17</xref>,<xref ref-type="bibr" rid="gkt529-B18">18</xref>). Techniques for data exploration include kernel density estimation and Gaussian mixture modelling with Bayesian information criterion regularization for unbiased cluster identification. Analysis of survival is included (<xref ref-type="bibr" rid="gkt529-B19">19</xref>), incorporating stratification based on mixture model results. Evidence is mounting that most phenotypes are governed by complex networks (<xref ref-type="bibr" rid="gkt529-B20">20</xref>,<xref ref-type="bibr" rid="gkt529-B21">21</xref>). TMA Navigator provides network inference approaches applicable to TMA datasets, which typically have relatively few markers. While several resources for TMA image data processing and management exist (<xref ref-type="bibr" rid="gkt529-B22 gkt529-B23 gkt529-B24 gkt529-B25">22–25</xref>), few user-friendly tools provide tailored workflows for data analysis and integration with clinical variables. Stanford TMA software (<xref ref-type="bibr" rid="gkt529-B26">26</xref>) and X-tile (<xref ref-type="bibr" rid="gkt529-B27">27</xref>) are notable, but provide comparatively restricted functionality. Study of marker relationships in clinical samples contributes to the development and testing of hypotheses about control of medically relevant phenotypes, such as treatment response or metastasis (<xref ref-type="bibr" rid="gkt529-B21">21</xref>).</p>
  </sec>
  <sec>
    <title>USAGE</title>
    <p>A flowchart summarizing the steps involved in using TMA Navigator (<ext-link ext-link-type="uri" xlink:href="www.tmanavigator.org">www.tmanavigator.org</ext-link>) is given in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Figure S1</ext-link> and includes embedded hyperlinks to relevant parts of the user guide. Extensive help documentation is available by clicking on the <italic>Help</italic> button near the top-right of any page on the website, which opens at the section relevant to the current page. Many parts of the website have context-sensitive help, including tooltips and links from headings to appropriate subsections of the user guide. The first step in working with TMA Navigator is to create a dataset by importing marker scores, typically protein expression values; survival information can also be uploaded. A unique page for the dataset (the ‘dataset page’) has a <italic>Run analysis</italic> button providing access to data exploration, network inference and survival analysis. Analyses are processed in a queuing system and results are accessed from the dataset page.</p>
    <sec>
      <title>Importing data</title>
      <p>TMA Navigator has a button labelled <italic>Add dataset</italic> near the top-right of every page to start the process of importing marker data. A grid format is required, with markers as columns and samples as rows. Marker replicates are specified by multiple columns with identical names. File formats accepted are Microsoft Excel (.xls, .xlsx), tab-separated (.tsv, .txt) or comma-separated values (.csv). For anonymous guest users, an imported dataset receives a unique URL, which is easily bookmarked and protected by a random key. Alternatively, users may register an account, which provides a single point of reference for multiple uploaded datasets.</p>
      <p>Tissue microarray datasets are often split across multiple TMA blocks, which can lead to unwanted non-biological variation (batch effects). TMA Navigator provides an option for batch effect reduction using ComBat (<xref ref-type="bibr" rid="gkt529-B17">17</xref>). We have adapted ComBat for use with TMAs, including improved error handling and automatic removal of replicates/markers that prove problematic due to missing data. Batch correction is offered during data import when batch information is included with marker scores—batches are indicated by a column named <italic>*Batch</italic> and covariates specified with a column name including the prefix <italic>*cov</italic>. Additional information on batch correction is provided at <ext-link ext-link-type="uri" xlink:href="http://www.tmanavigator.org/help/score-requirements#batches">www.tmanavigator.org/help/score-requirements#batches</ext-link>.</p>
      <p>Survival data are uploaded using the <italic>Attach survival</italic> button located on the dataset page. Patient identifiers in the TMA marker and survival data must match; anonymous patient identifiers such as a sequential numeric value must be used. The user guide (<ext-link ext-link-type="uri" xlink:href="www.tmanavigator.org/help">www.tmanavigator.org/help</ext-link>) gives further details on data import and formatting requirements.</p>
    </sec>
    <sec>
      <title>Data exploration</title>
      <p>Marker distributions may be visualized using density plots (continuous data) or histograms (categorical data). Samples may be clustered by modelling marker expression as a mixture of Gaussian distributions. The number of clusters is determined automatically, and the procedure is fully unsupervised (methods). The mixture model is plotted with the centre of each cluster indicated, overlaid with a density plot and histogram; model parameters are displayed in a sidebar. Risk stratification according to marker values is commonly done manually or with quantiles (<xref ref-type="bibr" rid="gkt529-B4">4</xref>,<xref ref-type="bibr" rid="gkt529-B28">28</xref>,<xref ref-type="bibr" rid="gkt529-B29">29</xref>). Mixture modelling with appropriate regularization (methods) has significant advantages, providing fully automated and statistically well-founded identification of groups according to expression values. Marker relationships may be explored with a heatmap (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Figure S2</ext-link>).</p>
      <p><xref ref-type="fig" rid="gkt529-F1">Figure 1</xref> shows a mixture model for the protein E-cadherin in the dataset ‘Breast Cancer 1’ (Demonstration data). The suffix ‘Cy-Mem’ indicates cytoplasmic and membrane expression values (i.e. non-nuclear). E-cadherin is a clinically important adhesion protein that is putatively down-regulated in epithelial to mesenchymal transition (EMT) and metastasis (<xref ref-type="bibr" rid="gkt529-B30 gkt529-B31 gkt529-B32">30–32</xref>). Mixture modelling identified two groups, ‘E-cadherin low’ (<italic>n</italic> = 10, mean score = 705) and ‘E-cadherin high’ (<italic>n</italic> = 118, mean score = 3769). Survival of these groups was investigated in TMA Navigator (<xref ref-type="fig" rid="gkt529-F2">Figure 2</xref>); the ‘E-cadherin low’ group showed a trend for worse survival, consistent with expectations (<xref ref-type="bibr" rid="gkt529-B28">28</xref>,<xref ref-type="bibr" rid="gkt529-B31">31</xref>,<xref ref-type="bibr" rid="gkt529-B33">33</xref>).
<fig id="gkt529-F1" position="float"><label>Figure 1.</label><caption><p>Gaussian mixture model of non-nuclear E-cadherin expression in primary invasive ductal breast tumours (demonstration dataset ‘Breast Cancer 1’). The histogram (black outlined bars) and kernel density estimation plot (solid blue line) both indicate protein expression. The mixture model is shown as a dotted turquoise line. Two patient groups were identified; the mean expression value for each group is shown by a vertical dotted line, and mixture model parameters are given on the right of the figure. The tabbed interface (top) allows easy navigation between markers.</p></caption><graphic xlink:href="gkt529f1p"/></fig>
<fig id="gkt529-F2" position="float"><label>Figure 2.</label><caption><p>Survival analysis with E-cadherin expression informed by mixture modelling. Kaplan–Meier plot: x-axis denotes overall survival in months, y-axis the proportion of the group alive. Stratification of invasive ductal breast cancers by mixture modelling of E-cadherin expression (AQUA data); the low-expressing group shows a trend for worse prognosis consistent with expectations. Marker tabs shown in red indicate single group (unimodal) mixture models, for which Kaplan–Meier plots are not available.</p></caption><graphic xlink:href="gkt529f2p"/></fig></p>
    </sec>
    <sec>
      <title>Survival analysis</title>
      <p>Survival analysis involves statistical testing to examine relationships of marker scores with survival, accounting for censoring, for a review see (<xref ref-type="bibr" rid="gkt529-B34">34</xref>). Groups are defined according to marker scores with survival displayed as a Kaplan–Meier plot (<xref ref-type="bibr" rid="gkt529-B19">19</xref>). The difference in survival between groups is tested for significance using the Mantel-Cox log-rank test (<xref ref-type="bibr" rid="gkt529-B35">35</xref>) with false discovery rate (FDR) correction applied (<xref ref-type="bibr" rid="gkt529-B36">36</xref>). <xref ref-type="fig" rid="gkt529-F2">Figure 2</xref> and <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Figure S3</ext-link> show Kaplan–Meier plots for E-cadherin and PTEN expression respectively on ‘Breast Cancer 1’ (invasive ductal) and ‘Breast Cancer 3’ (trastuzumab-treated) cohorts (Demonstration data). Grouping according to E-cadherin expression (<xref ref-type="fig" rid="gkt529-F2">Figure 2</xref>) was determined by mixture modelling, a fully unsupervised approach (Data exploration). Loss of E-cadherin confers poor prognosis (<xref ref-type="bibr" rid="gkt529-B30">30</xref>,<xref ref-type="bibr" rid="gkt529-B31">31</xref>,<xref ref-type="bibr" rid="gkt529-B33">33</xref>), and the low-expressing group showed the expected trend for worse survival. TMA Navigator provides for survival analyses on mixture modelling results as the option ‘Kaplan–Meier (mixture model) plots’ in the <italic>Run analysis</italic> dialogue box. <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Figure S3</ext-link> shows survival for tertiles of PTEN expression (FDR <italic>P</italic> = 0.0207), a tumour suppressor important for trastuzumab response (<xref ref-type="bibr" rid="gkt529-B37">37</xref>) scored using the semi-continuous ‘quickscore’ method (Demonstration data). Splitting by tertiles provides roughly equal group sizes and so may improve prospects of obtaining statistical significance (<xref ref-type="bibr" rid="gkt529-B38">38</xref>). However, these groups are unlikely to reflect modes of the underlying marker score distribution. Mixture modelling provides for biologically motivated grouping and so may enable better risk stratification, although associated smaller group sizes can lead to lower statistical power (<xref ref-type="bibr" rid="gkt529-B38">38</xref>). When mixture modelling returns a single Gaussian (unimodal) model, survival analysis is still possible using tertiles. For categorical data, groups are defined by score values.</p>
    </sec>
    <sec>
      <title>Network inference</title>
      <p>Correlation networks provide a useful abstraction of the relationships (edges) between multiple markers, for example to inform biomarker discovery (<xref ref-type="bibr" rid="gkt529-B39">39</xref>). TMA Navigator is typically used for analysis of protein expression, although markers might also include clinical variables such as lymph node metastasis count. TMA studies usually involve relatively few proteins that may have close relationships in signalling and/or metabolic pathways; therefore, common assumptions about network structure such as sparsity (<xref ref-type="bibr" rid="gkt529-B40">40</xref>,<xref ref-type="bibr" rid="gkt529-B41">41</xref>) do not necessarily hold. Furthermore, TMA data are subject to multiple sources of confounding variation that may be extremely challenging to remove, including differences in surgical procedure, sample age, reagent batch/age, sample fixation and variation in the material analysed. This variation acts as ‘noise’ and may reduce correlation values even when markers have biological relationships (<xref ref-type="bibr" rid="gkt529-B17">17</xref>). Accordingly, edge thresholding for TMA networks is usefully tailored to the individual dataset studied, and to enable this, TMA Navigator affords access to correlation values for all marker pairs. Statistical significance is normally applied to identify minimum threshold values (e.g. FDR <italic>P</italic>-value ≤ 0.05). Correlations can identify biologically meaningful edges (<xref ref-type="bibr" rid="gkt529-B42">42</xref>,<xref ref-type="bibr" rid="gkt529-B43">43</xref>); however, statistically significant correlations do not necessarily underlie genuine functional interactions (<xref ref-type="bibr" rid="gkt529-B44">44</xref>). Ideally, the edge threshold may be calibrated against negative control markers unrelated to the pathway(s) studied, as well as positive controls where relationships are well characterized in the system of interest.</p>
      <p>Correlation networks may be inferred in TMA Navigator using several measures: mutual information, Spearman correlation or Pearson correlation. Mutual information measures statistical dependency between markers and therefore detects many types of interaction, although does not distinguish between positive and negative relationships. Also, significance is estimated by permutation and therefore statistical power is influenced by sample size and dependencies within the data (<xref ref-type="bibr" rid="gkt529-B45">45</xref>). Spearman and Pearson correlation are limited to detecting monotonic and linear marker relationships respectively, but have the advantage of analytical significance estimation (methods) and can identify signed edges. Interactive thresholding is available on <italic>P</italic>-values adjusted for multiple hypothesis testing [Benjamini–Yekutieli (<xref ref-type="bibr" rid="gkt529-B46">46</xref>) or Bonferroni correction], displayed as an interactive network using the Cytoscape Web plugin (<xref ref-type="bibr" rid="gkt529-B47">47</xref>).</p>
      <p><xref ref-type="fig" rid="gkt529-F3">Figure 3</xref> shows a Spearman correlation network for the dataset ‘Breast Cancer 2’ (Demonstration data), thresholded at FDR <italic>P</italic> ≤ 0.05 (<xref ref-type="bibr" rid="gkt529-B46">46</xref>). Three components are identified, one (top-left) with the expected positive relationship between C35 and HER2 (<xref ref-type="bibr" rid="gkt529-B48">48</xref>) and negative relationship between HER2 and ER-α (<xref ref-type="bibr" rid="gkt529-B49">49</xref>). Interestingly, a positive relationship between C35 and MAL2 is found, in contrast to PCR results in cell culture with C35 induction (<xref ref-type="bibr" rid="gkt529-B48">48</xref>). The second component (bottom) includes expected edges between the EMT transcription factors Snail, Slug, ZEB1 (<xref ref-type="bibr" rid="gkt529-B30">30</xref>). The third component (top-right) includes edges between E-cadherin, Claudin-7 and β-catenin, as expected (<xref ref-type="bibr" rid="gkt529-B30">30</xref>,<xref ref-type="bibr" rid="gkt529-B48">48</xref>), suggesting a primary role for β-catenin in adhesion in this cohort, although an edge between nuclear β-catenin and Snail occurs close to the significance threshold (FDR <italic>P</italic> = 0.0783).
<fig id="gkt529-F3" position="float"><label>Figure 3.</label><caption><p>Spearman correlation network for trastuzumab-treated breast cancers. All marker pairs were scored using Spearman correlation and significant edges (FDR <italic>P</italic> ≤ 0.05) are shown. Colour of network nodes (markers) ranges from blue to orange, indicating low to high degree (number of significant connections). Positive and negative edges are respectively shown in grey and red. The network can be explored interactively, for example to alter layout and set significance threshold. Clicking on a marker summarizes neighbours, clicking on an edge displays the Spearman correlation and <italic>P</italic>-value. The above network recapitulates several expected interactions including a cluster of proteins that promote EMT (Snail, Slug, Vimentin, ZEB1) and an adhesion cluster (E-cadherin, β-catenin, Claudin-7) (<xref ref-type="bibr" rid="gkt529-B30">30</xref>). Networks may also be exported as GraphML for use with external software or as a PNG or SVG image.</p></caption><graphic xlink:href="gkt529f3p"/></fig></p>
    </sec>
    <sec>
      <title>Demonstration data</title>
      <p>Several example datasets are available to demonstrate the capabilities of TMA Navigator (<ext-link ext-link-type="uri" xlink:href="www.tmanavigator.org/demo">www.tmanavigator.org/demo</ext-link>). The dataset ‘Breast Cancer 1’ includes expression data for nine markers obtained using AQUA (<xref ref-type="bibr" rid="gkt529-B16">16</xref>) and survival over 9 years for a cohort of 128 lymph node positive patients (<xref ref-type="bibr" rid="gkt529-B10">10</xref>). The dataset ‘Breast Cancer 2’ has AQUA expression for 16 markers and survival over 5 years for a cohort of 92 trastuzumab-treated patients (<xref ref-type="bibr" rid="gkt529-B37">37</xref>). The dataset ‘Breast Cancer 3’ includes expression for four markers measured using a semi-continuous approach and survival over 5 years on 122 trastuzumab-treated patients (<xref ref-type="bibr" rid="gkt529-B37">37</xref>). The latter dataset has also been discretized into five quantiles for demonstration of categorical data handling. Antibodies for the above datasets are summarized in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Table S1</ext-link>; all data are from primary tumours. The example datasets described above are available pre-imported in TMA Navigator, and may also be downloaded.</p>
    </sec>
  </sec>
  <sec sec-type="methods">
    <title>METHODS</title>
    <p>Density plots approximate the empirical score distribution non-parametrically with adaptive bandwidth kernel density estimation (<xref ref-type="bibr" rid="gkt529-B50">50</xref>,<xref ref-type="bibr" rid="gkt529-B51">51</xref>). Mixture modelling identifies clusters of samples using expectation-maximization (<xref ref-type="bibr" rid="gkt529-B52">52</xref>) to fit a mixture of Gaussian distributions to marker values. Each cluster has independent mean and standard deviation parameters, better aligning with biological expectations than fixed standard deviation. The number of clusters (modality) is selected using the Bayesian information criterion (BIC) (<xref ref-type="bibr" rid="gkt529-B53">53</xref>). Survival is examined by Kaplan–Meier analysis (<xref ref-type="bibr" rid="gkt529-B19">19</xref>), using the Mantel-Cox log-rank test (<xref ref-type="bibr" rid="gkt529-B35">35</xref>), and stratification determined per marker with Benjamini–Hochberg corrected <italic>P</italic>-values (<xref ref-type="bibr" rid="gkt529-B36">36</xref>). Network edge significance is determined using algorithm AS89 (<xref ref-type="bibr" rid="gkt529-B54">54</xref>) (Spearman if <italic>n</italic> &lt; 1290), Student t approximation (Spearman, Pearson) or permutation (mutual information), and <italic>P</italic>-values corrected with Benjamini–Yekutieli (recommended), or the overly conservative Bonferroni method (<xref ref-type="bibr" rid="gkt529-B46">46</xref>,<xref ref-type="bibr" rid="gkt529-B55">55</xref>). The service architecture is illustrated in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Figure S4</ext-link> and described in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Data</ext-link>.</p>
  </sec>
  <sec>
    <title>CONCLUDING REMARKS</title>
    <p>TMAs offer high-throughput immunohistochemical analysis of clinical samples and provide for study of tissue and cell-type specific networks underlying pathophenotypes (<xref ref-type="bibr" rid="gkt529-B4">4</xref>,<xref ref-type="bibr" rid="gkt529-B21">21</xref>). TMA Navigator is a unique interactive platform for TMA data processing and analysis that has been successfully tested on multiple web browsers (Internet Explorer, Firefox, Chrome, Opera, Safari). Key features include batch correction (<xref ref-type="bibr" rid="gkt529-B17">17</xref>), unsupervised stratification by marker scores, survival analysis and network inference. An extensive user guide and demonstration datasets are available. We very much appreciate feedback on any issues relating to TMA Navigator, ideally sent via the form at <ext-link ext-link-type="uri" xlink:href="www.tmanavigator.org/contact">www.tmanavigator.org/contact</ext-link>, and welcome requests for new functionality.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt529/-/DC1">Supplementary Data</ext-link> are available at NAR Online: Supplementary Table 1 and Supplementary Figures 1–4.</p>
  </sec>
</body>
<back>
  <ack>
    <title>ACKNOWLEDGEMENTS</title>
    <p>We thank Sylvie Dubois-Marshall, In Hwa Um and Helen Caldwell for contributing to collection of demonstration data. We are also grateful to everyone who helped with testing.</p>
  </ack>
  <sec>
    <title>FUNDING</title>
    <p><funding-source>Scottish Funding Council (SFC)</funding-source> and the <funding-source>Chief Scientist's Office (CSO)</funding-source> (to D.H.); <funding-source>Royal Society of Edinburgh Scottish Government Fellowship</funding-source> co-funded by <funding-source>Marie Curie Actions</funding-source> and the <funding-source>UK Medical Research Council (MRC)</funding-source> (to I.O.). Funding for open access charge: <funding-source>Royal Society of Edinburgh</funding-source>.</p>
    <p><italic>Conflict of interest statement.</italic> None declared.</p>
  </sec>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="gkt529-B1">
      <label>1</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vogelstein</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kinzler</surname>
            <given-names>KW</given-names>
          </name>
        </person-group>
        <article-title>Cancer genes and the pathways they control</article-title>
        <source>Nat. Med.</source>
        <year>2004</year>
        <volume>10</volume>
        <fpage>789</fpage>
        <lpage>799</lpage>
        <pub-id pub-id-type="pmid">15286780</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kolch</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Pitt</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Functional proteomics to dissect tyrosine kinase signalling pathways in cancer</article-title>
        <source>Nat. Rev. Cancer</source>
        <year>2010</year>
        <volume>10</volume>
        <fpage>618</fpage>
        <lpage>629</lpage>
        <pub-id pub-id-type="pmid">20720570</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kononen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bubendorf</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kallionimeni</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Barlund</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schraml</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Leighton</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Torhorst</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mihatsch</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Sauter</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kallionimeni</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <article-title>Tissue microarrays for high-throughput molecular profiling of tumor specimens</article-title>
        <source>Nat. Med.</source>
        <year>1998</year>
        <volume>4</volume>
        <fpage>844</fpage>
        <lpage>847</lpage>
        <pub-id pub-id-type="pmid">9662379</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Camp</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Neumeister</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Rimm</surname>
            <given-names>DL</given-names>
          </name>
        </person-group>
        <article-title>A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers</article-title>
        <source>J. Clin. Oncol.</source>
        <year>2008</year>
        <volume>26</volume>
        <fpage>5630</fpage>
        <lpage>5637</lpage>
        <pub-id pub-id-type="pmid">18936473</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Camp</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Charette</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Rimm</surname>
            <given-names>DL</given-names>
          </name>
        </person-group>
        <article-title>Validation of tissue microarray technology in breast carcinoma</article-title>
        <source>Lab. Invest.</source>
        <year>2000</year>
        <volume>80</volume>
        <fpage>1943</fpage>
        <lpage>1949</lpage>
        <pub-id pub-id-type="pmid">11140706</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Camp</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Dolled-Filhart</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>King</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Rimm</surname>
            <given-names>DL</given-names>
          </name>
        </person-group>
        <article-title>Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome</article-title>
        <source>Cancer Res.</source>
        <year>2003</year>
        <volume>63</volume>
        <fpage>1445</fpage>
        <lpage>1448</lpage>
        <pub-id pub-id-type="pmid">12670887</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Salto-Tellez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Putti</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Do</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Koay</surname>
            <given-names>ES</given-names>
          </name>
        </person-group>
        <article-title>Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer</article-title>
        <source>Mod. Pathol.</source>
        <year>2003</year>
        <volume>16</volume>
        <fpage>79</fpage>
        <lpage>85</lpage>
        <pub-id pub-id-type="pmid">12527717</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Paweletz</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Charboneau</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bichsel</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Simone</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gillespie</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Emmert-Buck</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Petricoin</surname>
            <given-names>EF</given-names>
            <suffix>III</suffix>
          </name>
          <name>
            <surname>Liotta</surname>
            <given-names>LA</given-names>
          </name>
        </person-group>
        <article-title>Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front</article-title>
        <source>Oncogene</source>
        <year>2001</year>
        <volume>20</volume>
        <fpage>1981</fpage>
        <lpage>1989</lpage>
        <pub-id pub-id-type="pmid">11360182</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Washburn</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Wolters</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yates</surname>
            <given-names>JR</given-names>
            <suffix>III</suffix>
          </name>
        </person-group>
        <article-title>Large-scale analysis of the yeast proteome by multidimensional protein identification technology</article-title>
        <source>Nat. Biotech.</source>
        <year>2001</year>
        <volume>19</volume>
        <fpage>242</fpage>
        <lpage>247</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dubois-Marshall</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Faratian</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Harrison</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Katz</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer</article-title>
        <source>Clin. Exp. Metastasis</source>
        <year>2011</year>
        <volume>28</volume>
        <fpage>811</fpage>
        <lpage>818</lpage>
        <pub-id pub-id-type="pmid">21789718</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lahrmann</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Halama</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sinn</surname>
            <given-names>HP</given-names>
          </name>
          <name>
            <surname>Schirmacher</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jaeger</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Grabe</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Automatic tumor-stroma separation in fluorescence TMAs enables the quantitative high-throughput analysis of multiple cancer biomarkers</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e28048</fpage>
        <pub-id pub-id-type="pmid">22164226</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Seligson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hemstreet</surname>
            <given-names>GP</given-names>
          </name>
        </person-group>
        <article-title>Protein expression analysis using quantitative fluorescence image analysis on tissue microarray slides</article-title>
        <source>Biotechniques</source>
        <year>2002</year>
        <volume>32</volume>
        <fpage>924</fpage>
        <lpage>926</lpage>
        <comment>928–930, 932</comment>
        <pub-id pub-id-type="pmid">11962614</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Allred</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Harvey</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Berardo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>GM</given-names>
          </name>
        </person-group>
        <article-title>Prognostic and predictive factors in breast cancer by immunohistochemical analysis</article-title>
        <source>Mod. Pathol.</source>
        <year>1998</year>
        <volume>11</volume>
        <fpage>155</fpage>
        <lpage>168</lpage>
        <pub-id pub-id-type="pmid">9504686</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCarty</surname>
            <given-names>KS</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Szabo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Flowers</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Leight</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Konrath</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Soper</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Budwit</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Creasman</surname>
            <given-names>WT</given-names>
          </name>
        </person-group>
        <article-title>Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors</article-title>
        <source>Cancer Res.</source>
        <year>1986</year>
        <volume>46</volume>
        <fpage>4244s</fpage>
        <lpage>4248s</lpage>
        <pub-id pub-id-type="pmid">3524805</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Detre</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saclani Jotti</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dowsett</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>A ‘quickscore’ method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas</article-title>
        <source>J. Clin. Pathol.</source>
        <year>1995</year>
        <volume>48</volume>
        <fpage>876</fpage>
        <lpage>878</lpage>
        <pub-id pub-id-type="pmid">7490328</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCabe</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dolled-Filhart</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Camp</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Rimm</surname>
            <given-names>DL</given-names>
          </name>
        </person-group>
        <article-title>Automated quantitative analysis (AQUA) of <italic>in situ</italic> protein expression, antibody concentration, and prognosis</article-title>
        <source>J. Natl Cancer Inst.</source>
        <year>2005</year>
        <volume>97</volume>
        <fpage>1808</fpage>
        <lpage>1815</lpage>
        <pub-id pub-id-type="pmid">16368942</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Johnson</surname>
            <given-names>WE</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rabinovic</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title>
        <source>Biostatistics</source>
        <year>2007</year>
        <volume>8</volume>
        <fpage>118</fpage>
        <lpage>127</lpage>
        <pub-id pub-id-type="pmid">16632515</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leek</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Scharpf</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Bravo</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Simcha</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Langmead</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>WE</given-names>
          </name>
          <name>
            <surname>Geman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Baggerly</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Irizarry</surname>
            <given-names>RA</given-names>
          </name>
        </person-group>
        <article-title>Tackling the widespread and critical impact of batch effects in high-throughput data</article-title>
        <source>Nat. Rev. Genet.</source>
        <year>2010</year>
        <volume>11</volume>
        <fpage>733</fpage>
        <lpage>739</lpage>
        <pub-id pub-id-type="pmid">20838408</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaplan</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Meier</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Nonparametric estimation from incomplete observations</article-title>
        <source>J. Am. Statist. Assoc.</source>
        <year>1958</year>
        <volume>53</volume>
        <fpage>457</fpage>
        <lpage>481</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vidal</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cusick</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Barabási</surname>
            <given-names>AL</given-names>
          </name>
        </person-group>
        <article-title>Interactome networks and human disease</article-title>
        <source>Cell</source>
        <year>2011</year>
        <volume>144</volume>
        <fpage>986</fpage>
        <lpage>998</lpage>
        <pub-id pub-id-type="pmid">21414488</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Barabasi</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Gulbahce</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Loscalzo</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Network medicine: a network-based approach to human disease</article-title>
        <source>Nat. Rev. Genet.</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>56</fpage>
        <lpage>68</lpage>
        <pub-id pub-id-type="pmid">21164525</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morris</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Tsui</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Crichton</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Maccallum</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Howat</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Davies</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brenton</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Caldas</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>A metadata-aware application for remote scoring and exchange of tissue microarray images</article-title>
        <source>BMC Bioinformatics</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>147</fpage>
        <pub-id pub-id-type="pmid">23635078</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B23">
      <label>23</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thallinger</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Baumgartner</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pirklbauer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Uray</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pauritsch</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mehes</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Buck</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zatloukal</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Trajanoski</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>TAMEE: data management and analysis for tissue microarrays</article-title>
        <source>BMC Bioinformatics</source>
        <year>2007</year>
        <volume>8</volume>
        <fpage>81</fpage>
        <pub-id pub-id-type="pmid">17343750</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B24">
      <label>24</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Demichelis</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Riva</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gibbs</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mahavishno</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Chinnaiyan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rubin</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Internet-based profiler system as integrative framework to support translational research</article-title>
        <source>BMC Bioinformatics</source>
        <year>2005</year>
        <volume>6</volume>
        <fpage>304</fpage>
        <pub-id pub-id-type="pmid">16364175</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B25">
      <label>25</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sharma-Oates</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Quirke</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Westhead</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>TmaDB: a repository for tissue microarray data</article-title>
        <source>BMC Bioinformatics</source>
        <year>2005</year>
        <volume>6</volume>
        <fpage>218</fpage>
        <pub-id pub-id-type="pmid">16137321</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B26">
      <label>26</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Prapong</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Natkunam</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Alizadeh</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Montgomery</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gilks</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>van de Rijn</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays</article-title>
        <source>Am. J. Pathol.</source>
        <year>2002</year>
        <volume>161</volume>
        <fpage>1557</fpage>
        <lpage>1565</lpage>
        <pub-id pub-id-type="pmid">12414504</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B27">
      <label>27</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Camp</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Dolled-Filhart</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rimm</surname>
            <given-names>DL</given-names>
          </name>
        </person-group>
        <article-title>X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization</article-title>
        <source>Clin. Cancer Res.</source>
        <year>2004</year>
        <volume>10</volume>
        <fpage>7252</fpage>
        <lpage>7259</lpage>
        <pub-id pub-id-type="pmid">15534099</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B28">
      <label>28</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Minin</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Seligson</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Horvath</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Statistical methods for analyzing tissue microarray data</article-title>
        <source>J. Biopharm. Stat.</source>
        <year>2004</year>
        <volume>14</volume>
        <fpage>671</fpage>
        <lpage>685</lpage>
        <pub-id pub-id-type="pmid">15468758</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B29">
      <label>29</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jamieson</surname>
            <given-names>NB</given-names>
          </name>
          <name>
            <surname>Carter</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>McKay</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Oien</surname>
            <given-names>KA</given-names>
          </name>
        </person-group>
        <article-title>Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis</article-title>
        <source>Clin. Cancer Res.</source>
        <year>2011</year>
        <volume>17</volume>
        <fpage>3316</fpage>
        <lpage>3331</lpage>
        <pub-id pub-id-type="pmid">21444679</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B30">
      <label>30</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thiery</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Acloque</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>RY</given-names>
          </name>
          <name>
            <surname>Nieto</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>Epithelial-mesenchymal transitions in development and disease</article-title>
        <source>Cell</source>
        <year>2009</year>
        <volume>139</volume>
        <fpage>871</fpage>
        <lpage>890</lpage>
        <pub-id pub-id-type="pmid">19945376</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B31">
      <label>31</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oka</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shiozaki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tahara</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takatsuka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Matsuyoshi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hirano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Takeichi</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis</article-title>
        <source>Cancer Res.</source>
        <year>1993</year>
        <volume>53</volume>
        <fpage>1696</fpage>
        <lpage>1701</lpage>
        <pub-id pub-id-type="pmid">8453644</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B32">
      <label>32</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Onder</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>PB</given-names>
          </name>
          <name>
            <surname>Mani</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lander</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Weinberg</surname>
            <given-names>RA</given-names>
          </name>
        </person-group>
        <article-title>Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways</article-title>
        <source>Cancer Res.</source>
        <year>2008</year>
        <volume>68</volume>
        <fpage>3645</fpage>
        <lpage>3654</lpage>
        <pub-id pub-id-type="pmid">18483246</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B33">
      <label>33</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taube</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Herschkowitz</surname>
            <given-names>JI</given-names>
          </name>
          <name>
            <surname>Komurov</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>AY</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hartwell</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Onder</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>PB</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>KW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2010</year>
        <volume>107</volume>
        <fpage>15449</fpage>
        <lpage>15454</lpage>
        <pub-id pub-id-type="pmid">20713713</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B34">
      <label>34</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Clark</surname>
            <given-names>TG</given-names>
          </name>
          <name>
            <surname>Bradburn</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Love</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Altman</surname>
            <given-names>DG</given-names>
          </name>
        </person-group>
        <article-title>Survival analysis part I: basic concepts and first analyses</article-title>
        <source>Br. J. Cancer</source>
        <year>2003</year>
        <volume>89</volume>
        <fpage>232</fpage>
        <lpage>238</lpage>
        <pub-id pub-id-type="pmid">12865907</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B35">
      <label>35</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mantel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Evaluation of survival data and two new rank order statistics arising in its consideration</article-title>
        <source>Cancer Chemother. Rep.</source>
        <year>1966</year>
        <volume>50</volume>
        <fpage>163</fpage>
        <lpage>170</lpage>
        <pub-id pub-id-type="pmid">5910392</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B36">
      <label>36</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamini</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hochberg</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>
        <source>J. Roy. Stat. Soc. Ser. B</source>
        <year>1995</year>
        <volume>57</volume>
        <fpage>289</fpage>
        <lpage>300</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B37">
      <label>37</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faratian</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Goltsov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lebedeva</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sorokin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Moodie</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mullen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kay</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Um</surname>
            <given-names>IH</given-names>
          </name>
          <name>
            <surname>Langdon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Goryanin</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab</article-title>
        <source>Cancer Res.</source>
        <year>2009</year>
        <volume>69</volume>
        <fpage>6713</fpage>
        <lpage>6720</lpage>
        <pub-id pub-id-type="pmid">19638581</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B38">
      <label>38</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schoenfeld</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The asymptotic properties of nonparametric tests for comparing survival distributions</article-title>
        <source>Biometrika</source>
        <year>1981</year>
        <volume>68</volume>
        <fpage>316</fpage>
        <lpage>319</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B39">
      <label>39</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Adourian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jennings</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Balasubramanian</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hines</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Damian</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Plasterer</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Clish</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Stroobant</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>McBurney</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Verheij</surname>
            <given-names>ER</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Correlation network analysis for data integration and biomarker selection</article-title>
        <source>Mol. Biosyst.</source>
        <year>2008</year>
        <volume>4</volume>
        <fpage>249</fpage>
        <lpage>259</lpage>
        <pub-id pub-id-type="pmid">18437268</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B40">
      <label>40</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Szederkényi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Banga</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Alonso</surname>
            <given-names>AA</given-names>
          </name>
        </person-group>
        <article-title>Inference of complex biological networks: distinguishability issues and optimization-based solutions</article-title>
        <source>BMC Syst. Biol.</source>
        <year>2011</year>
        <volume>5</volume>
        <fpage>177</fpage>
        <pub-id pub-id-type="pmid">22034917</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B41">
      <label>41</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yeung</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Tegnér</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>JJ</given-names>
          </name>
        </person-group>
        <article-title>Reverse engineering gene networks using singular value decomposition and robust regression</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2002</year>
        <volume>99</volume>
        <fpage>6163</fpage>
        <lpage>6168</lpage>
        <pub-id pub-id-type="pmid">11983907</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B42">
      <label>42</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Lund</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kiraly</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duke</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Eizinger</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wylie</surname>
            <given-names>BN</given-names>
          </name>
          <name>
            <surname>Davidson</surname>
            <given-names>GS</given-names>
          </name>
        </person-group>
        <article-title>A gene expression map for <italic>Caenorhabditis elegans</italic></article-title>
        <source>Science</source>
        <year>2001</year>
        <volume>293</volume>
        <fpage>2087</fpage>
        <lpage>2092</lpage>
        <pub-id pub-id-type="pmid">11557892</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B43">
      <label>43</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gillis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pavlidis</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>The role of indirect connections in gene networks in predicting function</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <fpage>1860</fpage>
        <lpage>1866</lpage>
        <pub-id pub-id-type="pmid">21551147</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B44">
      <label>44</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Venet</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Dumont</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Detours</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>most random gene expression signatures are significantly associated with breast cancer outcome</article-title>
        <source>PLoS Comput. Biol.</source>
        <year>2011</year>
        <volume>7</volume>
        <fpage>e1002240</fpage>
        <pub-id pub-id-type="pmid">22028643</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B45">
      <label>45</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>So</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sham</surname>
            <given-names>PC</given-names>
          </name>
        </person-group>
        <article-title>Multiple testing and power calculations in genetic association studies</article-title>
        <source>Cold Spring Harb. Protoc.</source>
        <year>2011</year>
        <volume>2011</volume>
        <comment>pdb.top95</comment>
      </element-citation>
    </ref>
    <ref id="gkt529-B46">
      <label>46</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamini</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yekutieli</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The control of the false discovery rate in multiple testing under dependency</article-title>
        <source>Ann. Statist.</source>
        <year>2001</year>
        <volume>29</volume>
        <fpage>1165</fpage>
        <lpage>1188</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B47">
      <label>47</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lopes</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Franz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kazi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Donaldson</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Bader</surname>
            <given-names>GD</given-names>
          </name>
        </person-group>
        <article-title>Cytoscape Web: an interactive web-based network browser</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <fpage>2347</fpage>
        <lpage>2348</lpage>
        <pub-id pub-id-type="pmid">20656902</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B48">
      <label>48</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Katz</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Dubois-Marshall</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sims</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Gautier</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Caldwell</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Meehan</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Harrison</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>An <italic>in vitro</italic> model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e17083</fpage>
        <pub-id pub-id-type="pmid">21347235</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt529-B49">
      <label>49</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cuzick</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dowsett</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wale</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Salter</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Quinn</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zabaglo</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Howell</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Buzdar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Forbes</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Prognostic value of a combined ER, PgR, Ki67, HER2 immunohistochemical (IHC4) score and comparison with the GHI recurrence score–results from TransATAC</article-title>
        <source>Cancer Res.</source>
        <year>2010</year>
        <volume>69</volume>
        <fpage>74</fpage>
        <lpage>74</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B50">
      <label>50</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rosenblatt</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Remarks on some nonparametric estimates of a density function</article-title>
        <source>Ann. Math Statist.</source>
        <year>1956</year>
        <volume>27</volume>
        <fpage>832</fpage>
        <lpage>837</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B51">
      <label>51</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Abramson</surname>
            <given-names>IS</given-names>
          </name>
        </person-group>
        <article-title>On bandwidth variation in kernel estimates—a square root law</article-title>
        <source>Ann. Statist.</source>
        <year>1982</year>
        <volume>10</volume>
        <fpage>1217</fpage>
        <lpage>1223</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B52">
      <label>52</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dempster</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Laird</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Rubin</surname>
            <given-names>DB</given-names>
          </name>
        </person-group>
        <article-title>Maximum likelihood from incomplete data via the EM Algorithm</article-title>
        <source>J. Roy. Stat. Soc. Ser. B</source>
        <year>1977</year>
        <volume>39</volume>
        <fpage>1</fpage>
        <lpage>38</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B53">
      <label>53</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schwarz</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Estimating the dimension of a model</article-title>
        <source>Ann. Statist.</source>
        <year>1978</year>
        <volume>6</volume>
        <fpage>461</fpage>
        <lpage>464</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B54">
      <label>54</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Best</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>DE</given-names>
          </name>
        </person-group>
        <article-title>Algorithm AS 89: the upper tail probabilities of spearman’s rho</article-title>
        <source>J. Roy. Stat. Soc. Ser. C</source>
        <year>1975</year>
        <volume>24</volume>
        <fpage>377</fpage>
        <lpage>379</lpage>
      </element-citation>
    </ref>
    <ref id="gkt529-B55">
      <label>55</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verhoeven</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Simonsen</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>McIntyre</surname>
            <given-names>LM</given-names>
          </name>
        </person-group>
        <article-title>Implementing false discovery rate control: increasing your power</article-title>
        <source>Oikos</source>
        <year>2005</year>
        <volume>108</volume>
        <fpage>643</fpage>
        <lpage>647</lpage>
      </element-citation>
    </ref>
  </ref-list>
</back>
